WO2004091627A3 - Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs - Google Patents
Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs Download PDFInfo
- Publication number
- WO2004091627A3 WO2004091627A3 PCT/US2004/010969 US2004010969W WO2004091627A3 WO 2004091627 A3 WO2004091627 A3 WO 2004091627A3 US 2004010969 W US2004010969 W US 2004010969W WO 2004091627 A3 WO2004091627 A3 WO 2004091627A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dihydro
- analogs
- oxo
- naphthpyridine
- heterocyclic substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04759328A EP1610795A4 (en) | 2003-04-07 | 2004-04-07 | Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46120503P | 2003-04-07 | 2003-04-07 | |
US60/461,205 | 2003-04-07 | ||
US51956903P | 2003-11-12 | 2003-11-12 | |
US60/519,569 | 2003-11-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004091627A2 WO2004091627A2 (en) | 2004-10-28 |
WO2004091627A3 true WO2004091627A3 (en) | 2004-11-25 |
Family
ID=33303039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/010969 WO2004091627A2 (en) | 2003-04-07 | 2004-04-07 | Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs |
Country Status (3)
Country | Link |
---|---|
US (2) | US7163948B2 (en) |
EP (1) | EP1610795A4 (en) |
WO (1) | WO2004091627A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7354916B2 (en) | 2003-04-07 | 2008-04-08 | Cylene Pharmaceuticals | Substituted quinobenzoxazine analogs |
EP1610759A4 (en) | 2003-04-07 | 2007-04-25 | Cylene Pharmaceuticals Inc | Substituted quinobenzoxazine analogs |
US7507727B2 (en) | 2003-04-07 | 2009-03-24 | Cylene Pharmaceuticals, Inc. | Substituted quinobenzoxazine analogs and methods of using thereof |
WO2004091627A2 (en) * | 2003-04-07 | 2004-10-28 | Cylene Pharmaceuticals, Inc. | Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs |
JP4858683B2 (en) * | 2005-01-20 | 2012-01-18 | アステラス製薬株式会社 | Process for producing quinolone derivative or salt thereof |
JP4853824B2 (en) * | 2005-01-20 | 2012-01-11 | アステラス製薬株式会社 | Pharmaceutical composition comprising a quinolone derivative as an active ingredient |
WO2006113509A2 (en) * | 2005-04-15 | 2006-10-26 | Cylene Pharmaceuticals, Inc. | Quinobenzoxazine analogs and methods of using thereof |
US20080119492A1 (en) * | 2005-07-29 | 2008-05-22 | Jean-Marie Lehn | Compositions and methods for treating cancer and other diseases characterized by abnormal cell proliferation |
US8470817B2 (en) * | 2009-10-26 | 2013-06-25 | Sunesis Pharmaceuticals, Inc. | Compounds and methods for treatment of cancer |
TW201722957A (en) * | 2015-09-15 | 2017-07-01 | 葛蘭素史克智慧財產(第二)有限公司 | Chemical compounds |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4324983A (en) * | 1977-09-15 | 1982-04-13 | Humiston Gerald F | Binary vapor cycle method of electrical power generation |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4324893A (en) | 1979-04-18 | 1982-04-13 | American Home Products Corporation | 4-Amino-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives |
US4559157A (en) | 1983-04-21 | 1985-12-17 | Creative Products Resource Associates, Ltd. | Cosmetic applicator useful for skin moisturizing |
LU84979A1 (en) | 1983-08-30 | 1985-04-24 | Oreal | COSMETIC OR PHARMACEUTICAL COMPOSITION IN AQUEOUS OR ANHYDROUS FORM WHOSE FATTY PHASE CONTAINS OLIGOMER POLYETHER AND NEW OLIGOMER POLYETHERS |
US4533663A (en) | 1984-04-26 | 1985-08-06 | Abbott Laboratories | Quino-benzothiazine antibacterial compounds |
US4820508A (en) | 1987-06-23 | 1989-04-11 | Neutrogena Corporation | Skin protective composition |
US4992478A (en) | 1988-04-04 | 1991-02-12 | Warner-Lambert Company | Antiinflammatory skin moisturizing composition and method of preparing same |
JPH0240379A (en) | 1988-07-28 | 1990-02-09 | Wakunaga Pharmaceut Co Ltd | Novel quinolone derivative |
US4938949A (en) | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US5318965A (en) | 1990-08-24 | 1994-06-07 | Abbott Laboratories | Quinobenzoxazine, antineoplastic agents |
IE912902A1 (en) | 1990-08-24 | 1992-02-26 | Abbott Lab | Quinbenzoxazine, quinobenzothiazine, and pyrido-acridine¹antineoplastic agents |
US5412098A (en) * | 1991-12-27 | 1995-05-02 | Wakunaga Seiyaku Kabushiki Kaisha | Quinolone derivative or salt thereof and antibacterial containing the same |
EP0787726B1 (en) | 1994-06-14 | 2001-11-28 | Dainippon Pharmaceutical Co., Ltd. | Novel compound, process for producing the same, and antitumor agent |
JP4323574B2 (en) * | 1995-12-13 | 2009-09-02 | 大日本住友製薬株式会社 | Antitumor agent |
CA2253710A1 (en) | 1996-04-25 | 1997-10-30 | Spectrametrix Inc. | Analyte assay using particulate labels |
WO1999040093A2 (en) | 1998-02-04 | 1999-08-12 | Board Of Regents, The University Of Texas System | Synthesis of quinobenzoxazine analogues with topoisomerase ii and quadruplex interactions for use as antineoplastic agents |
US20020049223A1 (en) | 1999-11-05 | 2002-04-25 | Elmore Steven W. | Quinoline and naphthyridine carboxylic acid antibacterials |
NZ525571A (en) | 2000-12-14 | 2004-09-24 | Procter & Gamble | Antimicrobial quinolones |
US6818654B2 (en) | 2002-03-12 | 2004-11-16 | Abbott Laboratories | Antibacterial compounds |
US8163769B2 (en) | 2002-03-12 | 2012-04-24 | Abbott Laboratories | Antibacterial compounds |
US6900224B2 (en) | 2002-07-31 | 2005-05-31 | The Procter & Gamble Company | Antimicrobial quinolones, their compositions and uses |
WO2004091627A2 (en) * | 2003-04-07 | 2004-10-28 | Cylene Pharmaceuticals, Inc. | Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs |
US7196200B2 (en) | 2004-01-21 | 2007-03-27 | Abbott Laboratories | Antibacterial compounds |
-
2004
- 2004-04-07 WO PCT/US2004/010969 patent/WO2004091627A2/en active Application Filing
- 2004-04-07 US US10/820,487 patent/US7163948B2/en not_active Expired - Fee Related
- 2004-04-07 EP EP04759328A patent/EP1610795A4/en not_active Withdrawn
-
2005
- 2005-06-27 US US11/167,488 patent/US20070010512A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4324983A (en) * | 1977-09-15 | 1982-04-13 | Humiston Gerald F | Binary vapor cycle method of electrical power generation |
Non-Patent Citations (2)
Title |
---|
SANTILLI A.A.: "Synthesis and antibacterial evaluation of 1,2,3,4-tetrahydro-4-oxo-1,8-naphthyridine-3-carboxylic acid ester, carbonitriles and carboxamides", J. MED. CHEM., vol. 18, no. 10, April 1975 (1975-04-01), pages 1038 - 1041, XP002982920 * |
See also references of EP1610795A4 * |
Also Published As
Publication number | Publication date |
---|---|
EP1610795A4 (en) | 2007-10-24 |
US20050004160A1 (en) | 2005-01-06 |
WO2004091627A2 (en) | 2004-10-28 |
US20070010512A1 (en) | 2007-01-11 |
EP1610795A2 (en) | 2006-01-04 |
US7163948B2 (en) | 2007-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006113509A3 (en) | Quinobenzoxazine analogs and methods of using thereof | |
WO2004091504A3 (en) | Substituted quinobenzoxazine analogs | |
WO2005110410A3 (en) | Kinase inhibitors as therapeutic agents | |
TW200728307A (en) | Novel spirochromanone derivatives | |
EP1724262A4 (en) | 1-(2h)-isoquinolone derivative | |
MXPA05009508A (en) | 6-substituted nicotinamide derivatives as opioid receptor antagonists. | |
WO2008005542A3 (en) | Antiviral phosphinate compounds | |
WO2002024632A3 (en) | Substituted aminopropoxyaryl derivatives useful as agonists for lxr | |
WO2003082205A3 (en) | Compounds and methods | |
WO2002057252A3 (en) | Heterocyclic sulfonamide inhibitors of beta amyloid production | |
WO2008005368A3 (en) | Piperazines as p2x7 antagonists | |
WO2004056786A3 (en) | Pyrimidine derivates for the treatment of abnormal cell growth | |
WO2001019828A3 (en) | Kinase inhibitors as therapeutic agents | |
EP1674452A4 (en) | Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor | |
NO20052074L (en) | Substituted benzoxazinones and uses thereof. | |
WO2007084914A3 (en) | Phenoxy-substituted pyrimidines as adenosine receptor antagonists | |
WO2007109578A3 (en) | Substituted gamma lactams as prostaglandin ep2 agonists | |
TW200637539A (en) | CTGF inhibitors | |
CA2511255A1 (en) | 2-piperidone derivatives as prostaglandin agonists | |
WO2007017728A3 (en) | Novel heterocyclic compounds | |
WO2007014839A3 (en) | Cathepsin k inhibitors | |
WO2004091627A3 (en) | Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs | |
WO2004111008A3 (en) | Use of a compound of formula i for making a pharmaceutical composition | |
WO2003101996A3 (en) | Esters in position 20 of camptothecins | |
WO2005005461A3 (en) | Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004759328 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004759328 Country of ref document: EP |